MLANA and neoplasm: Under short-term priming conditions of only seven days, we failed to detect any tumor-specific killing of MART-1/Melan-A-expressing tumor cells nor did we detect enrichment of MART-1/Melan-A-multimer-positive T cells (data not shown).